Menu
Back to User profile » Professor Arschang Valipour
Papers published by Professor Arschang Valipour:
Physical Activity, Depression and Quality of Life in COPD – Results from the CLARA II Study
Horner A, Olschewski H, Hartl S, Valipour A, Funk GC, Studnicka M, Merkle M, Kaiser B, Wallner EM, Brecht S, Lamprecht B
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2755-2767
Published Date: 29 November 2023
RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD
Koblizek V, Milenkovic B, Svoboda M, Kocianova J, Holub S, Zindr V, Ilic M, Jankovic J, Cupurdija V, Jarkovsky J, Popov B, Valipour A
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2661-2672
Published Date: 17 November 2023
Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study
Valipour A, Avdeev S, Barczyk A, Bayer V, Fridlender Z, Georgieva M, Kudela O, Medvedchikov A, Miron R, Sanzharovskaya M, Šileikienė V, Šorli J, Spielmanns M, Szalai Z
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:615-628
Published Date: 10 March 2021
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
Valipour A, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Conway F, Duller M, Mayse M, Norman HS, Slebos DJ
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2807-2816
Published Date: 5 November 2020
Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
Valipour A, Tamm M, Kociánová J, Bayer V, Sanzharovskaya M, Medvedchikov A, Haaksma-Herczegh M, Mucsi J, Fridlender Z, Toma C, Belevskiy A, Matula B, Šorli J
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2343-2354
Published Date: 11 October 2019
Long-term safety of bilateral targeted lung denervation in patients with COPD
Valipour A, Asadi S, Pison C, Jondot M, Kessler R, Benneddif K, Deslee G, Verdier M, Slebos DJ, Mayse M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2163-2172
Published Date: 16 July 2018
Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
Ariel A, Altraja A, Belevskiy A, Boros PW, Danila E, Fležar M, Koblizek V, Fridlender ZG, Kostov K, Krams A, Milenkovic B, Somfay A, Tkacova R, Tudoric N, Ulmeanu R, Valipour A
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:45-56
Published Date: 21 December 2017
Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD
Urban MH, Eickhoff P, Funk GC, Burghuber OC, Wolzt M, Valipour A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:169-176
Published Date: 4 January 2017
POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
Zbozinkova Z, Barczyk A, Tkacova R, Valipour A, Tudoric N, Zykov K, Somfay A, Miravitlles M, Koblizek V
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:611-622
Published Date: 22 March 2016
Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema
Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:397-405
Published Date: 18 July 2012